Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced ...

That’s a vital question, because the same fundamental science addresses very different, but equally critical, challenges in ...

Lecanemab received traditional approval in the U.S. in July 2023 for the treatment of early Alzheimer's disease (AD). This retrospective study was conducted to investigate the actual state of ...

Mary Pat Mirus, 72, started to realize her balance suffering and struggled to move around without support. But a new ...

COVID Had a Startling Impact on Our Brains, New Research Says—Here's What a Neurologist Wants You to Do first appeared on ...

The itching, redness and swelling of an allergic reaction are caused by mast cells — the vigilant first responders of the immune system that spring ...

Your circadian rhythm influences mood, metabolism and even how well you respond to medical treatment. Now we finally have the ...

Allen Institute to employ Iterative Mapping, Nautilus’ single-molecule proteomics method, to investigate connection between tau protein and Alzheimer’s disease ...

Alpha Cognition's ZUNVEYL targets Alzheimer's with improved tolerability over existing galantamine therapies. Read why I rate ...

Feeling foggy, distracted, or forgetful? You're not alone. In a fast paced world where multitasking is the norm, your brain needs the right fuel to keep up. But you don’t need pricey supplements or ...

Shane Tamura, the gunman who killed four people inside a New York office this week before turning the gun on himself, was ...